{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:34:20Z","timestamp":1758944060906},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.cll.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T22:47:07Z","timestamp":1505947627000},"page":"803-819","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Flow Cytometric Assessment of Chronic Myeloid Neoplasms"],"prefix":"10.1016","volume":"37","author":[{"given":"Min","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragan","family":"Jevremovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2017.07.006_bib1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1182\/asheducation-2015.1.294","article-title":"Reclassifying myelodysplastic syndromes: what's where in the new WHO and why","volume":"2015","author":"Arber","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"20","key":"10.1016\/j.cll.2017.07.006_bib2","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cll.2017.07.006_bib3","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"88","article-title":"Myelodysplastic syndromes\/neoplasms, overview","author":"Brunning","year":"2008"},{"issue":"6","key":"10.1016\/j.cll.2017.07.006_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jcp.40.6.652","article-title":"Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid","volume":"40","author":"Clark","year":"1987","journal-title":"J\u00a0Clin Pathol"},{"issue":"1\u20132","key":"10.1016\/j.cll.2017.07.006_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10428199509054749","article-title":"Myelopoiesis in myelodysplasia evaluated by multiparameter flow cytometry","volume":"20","author":"Jensen","year":"1995","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.cll.2017.07.006_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0145-2126(93)90149-F","article-title":"A\u00a0quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry","volume":"17","author":"Jensen","year":"1993","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.1994.tb05042.x","article-title":"Complement receptor type 1 (CR1) deficiency on neutrophils in myelodysplastic syndrome","volume":"88","author":"Ohsaka","year":"1994","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2141.1986.tb02927.x","article-title":"DNA content and cell cycle analysis of bone marrow cells in myelodysplastic syndromes (MDS)","volume":"62","author":"Peters","year":"1986","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib9","first-page":"181","article-title":"Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukemias","volume":"30","author":"Riccardi","year":"1986","journal-title":"Basic Appl Histochem"},{"issue":"3","key":"10.1016\/j.cll.2017.07.006_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ajh.2830220305","article-title":"Myeloid cell surface phenotype in myelodysplasia: evidence for abnormal persistence of an early myeloid differentiation antigen","volume":"22","author":"Baumann","year":"1986","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1309\/6PBP78G4FBA1FDG6","article-title":"Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia","volume":"124","author":"Kussick","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.cll.2017.07.006_bib12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1309\/CAUT52HJ535P9UG2","article-title":"Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders","volume":"120","author":"Kussick","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.cll.2017.07.006_bib13","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1182\/blood-2002-01-0222","article-title":"Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome","volume":"100","author":"Ogata","year":"2002","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cll.2017.07.006_bib14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1080\/10428190500142155","article-title":"Clinical implications of blast immunophenotypes in myelodysplastic syndromes","volume":"46","author":"Ogata","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.cll.2017.07.006_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0145-2126(99)00194-0","article-title":"Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia","volume":"24","author":"Otawa","year":"2000","journal-title":"Leuk Res"},{"issue":"6","key":"10.1016\/j.cll.2017.07.006_bib16","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1309\/J3ET7RXD1X4BKDLF","article-title":"Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common","volume":"125","author":"Pirruccello","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.cll.2017.07.006_bib17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1182\/blood.V98.4.979","article-title":"Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome","volume":"98","author":"Stetler-Stevenson","year":"2001","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cll.2017.07.006_bib18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2009.008532","article-title":"Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study","volume":"94","author":"Ogata","year":"2009","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.cll.2017.07.006_bib19","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/leu.2014.191","article-title":"Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International\/European LeukemiaNet Working Group for Flow Cytometry in MDS","volume":"28","author":"Porwit","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.cll.2017.07.006_bib20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.2009.005801","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes","volume":"94","author":"van de Loosdrecht","year":"2009","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.cll.2017.07.006_bib21","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/leu.2012.30","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group","volume":"26","author":"Westers","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.cll.2017.07.006_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cytob.21160","article-title":"Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes","volume":"86","author":"Alhan","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"issue":"9","key":"10.1016\/j.cll.2017.07.006_bib23","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2009-08-239749","article-title":"Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment","volume":"115","author":"Westers","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2017.07.006_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/cyto.b.21087","article-title":"Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes","volume":"84","author":"Sandes","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"10.1016\/j.cll.2017.07.006_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cyto.b.20439","article-title":"Flow cytometric differential of leukocyte populations in normal bone marrow: influence of peripheral blood contamination","volume":"76","author":"Brooimans","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"10.1016\/j.cll.2017.07.006_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/cyto.b.20429","article-title":"Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses","volume":"76","author":"Loken","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"10.1016\/j.cll.2017.07.006_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cyto.b.21333","article-title":"Application of flow cytometry for myelodysplastic syndromes: pitfalls and technical considerations","volume":"90","author":"Alhan","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"issue":"5","key":"10.1016\/j.cll.2017.07.006_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1600-0609.2011.01676.x","article-title":"Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes","volume":"87","author":"Falco","year":"2011","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.cll.2017.07.006_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1309\/AJCP73QSLLYDEGXK","article-title":"Loss of blast heterogeneity in myelodysplastic syndrome and other chronic myeloid neoplasms","volume":"142","author":"Jevremovic","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1309\/4W2G3NDXUPG5J33N","article-title":"Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes","volume":"129","author":"Maftoun-Banankhah","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.cll.2017.07.006_bib31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/leu.2008.49","article-title":"The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal\/reactive and myelodysplastic syndrome precursors","volume":"22","author":"Matarraz","year":"2008","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.cll.2017.07.006_bib32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2007-07-098764","article-title":"Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry","volume":"111","author":"van de Loosdrecht","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cll.2017.07.006_bib33","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood.V98.8.2498","article-title":"Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry","volume":"98","author":"McKenna","year":"2001","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cll.2017.07.006_bib34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3324\/haematol.2011.048421","article-title":"Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study","volume":"97","author":"Della Porta","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.cll.2017.07.006_bib35","first-page":"6.37.1-30","article-title":"High-sensitivity detection of PNH Red blood cells, red cell precursors, and white blood cells","volume":"72","author":"Sutherland","year":"2015","journal-title":"Curr Protoc Cytom"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/aqw084","article-title":"Immunophenotypes of chronic myelomonocytic leukemia (CMML) subtypes by flow cytometry: a comparison of CMML-1 vs CMML-2, myeloproliferative vs dysplastic, De Novo vs therapy-related, and CMML-specific cytogenetic risk subtypes","volume":"146","author":"Harrington","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.cll.2017.07.006_bib37","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1309\/AJCPUY0ZMG3VTLFG","article-title":"Chronic myelomonocytic leukemia monocytes uniformly display a population of monocytes with CD11c underexpression","volume":"140","author":"Sojitra","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"23","key":"10.1016\/j.cll.2017.07.006_bib38","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1182\/blood-2015-01-620781","article-title":"Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia","volume":"125","author":"Selimoglu-Buet","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cll.2017.07.006_bib39","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3324\/haematol.2014.114660","article-title":"An International MDS\/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic\/myeloproliferative neoplasms","volume":"100","author":"Mughal","year":"2015","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cytob.21199","article-title":"Assessment of erythroid dysplasia by \u201cdifference from normal\u201d in routine clinical flow cytometry workup","volume":"88","author":"Eidenschink Brodersen","year":"2015","journal-title":"Cytometry B Clin Cytom"},{"issue":"10","key":"10.1016\/j.cll.2017.07.006_bib41","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/leu.2013.178","article-title":"Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes","volume":"27","author":"Mathis","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2016.147835","article-title":"Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group","volume":"102","author":"Westers","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cll.2017.07.006_bib43","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1309\/AJCPAGVO27RPTOTV","article-title":"Diagnostic potential of CD34+ cell antigen expression in myelodysplastic syndromes","volume":"138","author":"De Smet","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.cll.2017.07.006_bib44","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3324\/haematol.2008.004085","article-title":"Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes","volume":"94","author":"Goardon","year":"2009","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.cll.2017.07.006_bib45","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood-2002-01-0230","article-title":"Immunophenotypic clustering of myelodysplastic syndromes","volume":"100","author":"Maynadie","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2017.07.006_bib46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cyto.b.21108","article-title":"Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part V - assay performance criteria","volume":"84","author":"Wood","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"issue":"5","key":"10.1016\/j.cll.2017.07.006_bib47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1309\/AJCPFNF5MN1GDWKU","article-title":"The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders","volume":"134","author":"Harrington","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.cll.2017.07.006_bib48","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.leukres.2009.01.012","article-title":"The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study","volume":"33","author":"Truong","year":"2009","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3324\/haematol.2016.147843","article-title":"Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes","volume":"102","author":"Cremers","year":"2017","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.leukres.2007.06.012","article-title":"Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls","volume":"32","author":"Stachurski","year":"2008","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.cll.2017.07.006_bib51","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2005-12-4916","article-title":"Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes","volume":"108","author":"Ogata","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2017.07.006_bib52","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.leukres.2007.08.022","article-title":"Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes","volume":"32","author":"Satoh","year":"2008","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.cll.2017.07.006_bib53","doi-asserted-by":"crossref","first-page":"e8-10","DOI":"10.3324\/haematol.2013.097188","article-title":"Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia","volume":"99","author":"Della Porta","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.cll.2017.07.006_bib54","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cll.2017.07.006_bib55","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood-2008-05-153700","article-title":"Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome","volume":"112","author":"Scott","year":"2008","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.cll.2017.07.006_bib56","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1002\/cncr.25353","article-title":"Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data","volume":"116","author":"Kern","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.cll.2017.07.006_bib57","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cyto.b.21224","article-title":"Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: a study on 804 patients","volume":"88","author":"Kern","year":"2015","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"10.1016\/j.cll.2017.07.006_bib58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.2012.066787","article-title":"Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics","volume":"98","author":"Kern","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.cll.2017.07.006_bib59","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cyto.b.21068","article-title":"Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic\/myeloproliferative neoplasms","volume":"84","author":"Kern","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.cll.2017.07.006_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejca.2015.11.013","article-title":"Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias","volume":"54","author":"Cremers","year":"2016","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.cll.2017.07.006_bib61","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/leu.2015.295","article-title":"The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system","volume":"30","author":"Alhan","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.cll.2017.07.006_bib62","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1182\/blood.V124.21.5589.5589","article-title":"A\u00a0comparative assessment of flow cytometric scoring systems in MDS, in ASH","volume":"124","author":"Brodersen","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cll.2017.07.006_bib63","series-title":"Clinical manifestations and diagnosis of the myelodysplastic syndromes","author":"Aster","year":"2016"},{"key":"10.1016\/j.cll.2017.07.006_bib64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fonc.2016.00161","article-title":"Diagnostic utility of flow cytometry in myelodysplastic syndromes","volume":"6","author":"Aanei","year":"2016","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.cll.2017.07.006_bib65","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjh.12994","article-title":"High flow cytometric scores identify adverse prognostic subgroups within the revised International Prognostic Scoring System for myelodysplastic syndromes","volume":"167","author":"Alhan","year":"2014","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.cll.2017.07.006_bib66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cyto.b.20513","article-title":"Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients","volume":"78","author":"Matarraz","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"issue":"12","key":"10.1016\/j.cll.2017.07.006_bib67","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised International Prognostic Scoring System for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cll.2017.07.006_bib68","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/leu.2015.55","volume":"29","author":"Della Porta","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cll.2017.07.006_bib69","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1309\/AJCPBUMQJHVXHRD7","article-title":"Limited flow cytometry panels on bone marrow specimens reduce costs and predict negative cytogenetics","volume":"141","author":"Hoffmann","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.cll.2017.07.006_bib70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cyto.b.20607","article-title":"Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia","volume":"80","author":"Della Porta","year":"2011","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271217300689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271217300689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T03:46:44Z","timestamp":1719460004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271217300689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0272271217300689"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2017.07.006","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flow Cytometric Assessment of Chronic Myeloid Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}